Long QT

Prolonged duration of ventricular repolarisation which ↑ risk of polymorphic ventricular tachycardia. Polymorphic VT:

The QT interval varies with and must be corrected for the heart rate.

Bazett’s Formula suggests:

\[QTc = {QT \over \sqrt{R \textendash R \ Interval}}\]

Epidemiology and Risk Factors

Pathophysiology

Myocardial repolarisation:

  • Occurs due to a combination of:
    • Outward K+ flow
    • Inward Ca+ and Na+ flow
      Partially counters K+ current.
  • Is not homogenous between epicardium, mid-myocardium, and endocardial cells
    • Mid-myocardium is slower due to reduced K+ and Na+ channel density
      The tail of the T-wave tends to represent repolarisation of mid-myocardial cells.
  • ↓ mid-myocardial K+ or ↑ Na+ channel function in the mid-myocardium will therefore prolong the action potential
    • This may lead to late calcium inflow, and early after-depolarisations
      • If these EADs reach a threshold amplitude, VT may result

Aetiology

May be:

  • Congenital
    1/2,500-5,000. Multiple major genotypes have been developed, which include:
    • Jervell–Lange-Nielsen
      Autosomal recessive.
    • Romano–Ward
      Autosomal dominant.
  • Acquired
    Likely associated with some genetic abnormality. Include:
    • Drugs
    • Electrolyte abnormalities
    • Malnutrition
      In addition to any risk due to neurological abnormalities.
    • Neurological injury

Clinical Manifestations

History:

  • Sudden syncope
    30% of congenital present with syncope or aborted sudden death.
  • Pseudo-seizures during exercise or stress
  • Family history of sudden death

Diagnostic Approach and DDx

Investigations

ECG:

  • QTc >440ms
    May only be revealed in situations of physiological stress (e.g. a stress ECG.

Management

Resuscitation:

1g MgSO4 is ~4mmoL of Mg2+.

  • C
    • Polymorphic VT/VF
      • DC cardioversion
      • Mg2+
        Reduces EADs by ↑ encouraging resting repolarisation.
        • Given as 2g MgSO4 over 2-3 minutes
          May be repeated with another 2g after 15 minutes.
        • Consider infusion of 3-20mg/min if arrhythmias persist

Specific therapy:

  • Pharmacological
    • Antiarrhythmic
      • β-blockade
  • Procedural
    • Pacing
      HR and reduces QTc.
    • AICD

Supportive care:

Disposition:

Medical management:

  • β-blockade
  • Pacing
    HR and reduces QTc.
  • AICD

Potential Precipitants

Drugs associated with development of polymorphic VT:

  • Anti-arrhythmics
    • Sotalol
    • Amiodarone
    • Procainamide
    • Flecainide
    • Disopyramide
  • Antibiotics
    • Erythromycin
    • Clarithromycin
    • Fluconazole
  • Anti-psychotics
    • Droperidol
    • Haloperidol
  • Anti-depressants
    • Fluoxetine
  • Sympathomimetics
    • Ketamine

Anaesthetic Considerations

  • B
    • Maintain normocarbia
  • C
    • Malignant arrhythmia
      • High risk of intraoperative arrhythmia
      • May be precipitated by ↑ sympathetic tone
        • Intraoperative sympatholysis is crucial
      • Cardiology review pre-operatively is ideal
    • Avoid bradycardia
    • Avoid hypotension
  • E
    • Avoid reversal of neuromuscular block
      QTc is prolonged with neostigmine-glycopyrrolate.

Marginal and Ineffective Therapies

Complications

Prognosis

Key Studies


References

  1. Hunter JD, Sharma P, Rathi S. Long QT syndrome. Contin Educ Anaesth Crit Care Pain. 2008 Apr 1;8(2):67–70.